Laurus Labs Limited (LAURUSLABS) — Announcement | 12 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Laurus Labs to attend Motilal Oswal investor conference
💡 Investor Takeaway
The meeting offers direct engagement with investors but carries no new financial updates or guidance.

Laurus Labs announced its participation in the Motilal Oswal Annual Global Investor Conference on August 19, 2026, in Mumbai, offering one-on-one and group meetings with analysts and institutional investors. The filing confirms the event date is tentative and subject to change, with no unpublished price-sensitive information to be discussed.

📄 View Original Announcement (PDF)

About Laurus Labs Limited (LAURUSLABS)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,03,025.6 Cr P/E: 94.1 ROE: 20.6% ROCE: 20.8% Div Yield: 0.06%

View full LAURUSLABS stock details →

📡 Get AI alerts when LAURUSLABS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LAURUSLABS — Free

📊 More LAURUSLABS filings

See all LAURUSLABS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LAURUSLABS files new disclosures

Track LAURUSLABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LAURUSLABS — Free

Free account · 2 AI queries/day